Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	13.98B -7.6%
Revenue (ttm)	591.28M +45.8%
Net Income	180.33M +74.1%
EPS	1.31 +72.0%
Shares Out	137.75M
PE Ratio	77.76
Forward PE	74.64
Dividend	0.80 (0.79%)
Ex-Dividend Date	May 29, 2025

Volume	527,010
Average Volume	364,064
Open	103.39
Previous Close	103.19
Day's Range	101.11 - 103.50
52-Week Range	95.28 - 132.94
Beta	0.18
RSI	32.84
Earnings Date	Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2024, SHA:688198's revenue was 501.88 million, an increase of 35.41% compared to the previous year's 370.64 million. Earnings were 146.33 million, an increase of 27.02%.